DiscGenics completed enrollment in its Phase I/II first-in-human U.S. clinical study of injectable disc cell therapy to treat degenerative disc disease.
Biocomposites commenced U.S. launch of STIMULAN® Rapid Cure 3cc synthetic calcium sulfate, designed specifically for smaller voids in the foot and ankle.
Amplify Surgical's dualXâ„¢ Expanding Interbody Fusion System has been implanted in 300 surgical levels to date. Initial alpha launch commenced in 1Q19.
Corin's OMNIBotics robotic-assisted platform has completed 25,000Â TKAs, including 5,000 procedures assisted with the BalanceBot ligament balancing robotic device.